Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer, Nonlinear Dynamics, PSI, Applied Biosystems, CombiMatrix, Polypeptide Laboratories, NeoMPS

PerkinElmer Bundling Geliance with Nonlinear’s Progenesis Software
PerkinElmer will supply Nonlinear Dynamics’ Progenesis SameSpots 2D gel software with its Geliance 1000 Imaging Systems, the companies announced this week. Terms of the agreement were not released.
PerkinElmer released the Geliance platform at the Human Proteome Organization’s annual conference in Seoul in October.

PSI Seeking Comment
The Proteomics Standards Initiative’s document “mzML: Mass Spectrometry Markup Language Specification” is now available for public comment, PSI said this week. The document, available here, is part of HUPO’s PSI’s efforts at standardization in the proteomics field.
PSI is asking for both negative and positive comments. Those who do not want to make their comments public can send them directly to PSI Editor Norman Paton at [email protected].

Applera Declares Dividend for ABI Shareholders
Applera last week said its board declared a regular quarterly dividend of $.0425 for each share of Applera-Applied Biosystems stock. The dividend is payable on Jan. 2, 2008, for shareholders of record as of the close of business day Dec. 3.

CombiMatrix Stock Moves up Nasdaq Tier
CombiMatrix’s stock began trading on the Nasdaq Global Market on Nov. 19. Since splitting from Acacia Research in August [See PM 08/16/07], the company’s stock had been trading on the Nasdaq Capital Market. The Global Market is considered the second of the three tiers making up the Nasdaq exchange and has more stringent listing requirements than the Capital Market tier.

PolyPeptide Buys NeoMPS, Ramps up Capacity
PolyPeptides Laboratories Group said this week it has acquired peptide manufacturer NeoMPS from Isochem for an undisclosed amount.

The acquisition increases PolyPeptide’s manufacturing capacity and capabilities to large-scale peptides from small-scale custom peptides, it said in a statement. As a result of the deal, PolyPeptide now has facilities in Strasbourg, France; San Diego; Torrance, Calif.; Hillerod, Denmark; and Malmo, Sweden.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.